These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 282898)

  • 1. Usefulness of cell kinetics for staging of chronic myeloid leukemia?
    Stryckmans P; Ronge-Collard E; Debusscher L; Peyer A
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):271-7. PubMed ID: 282898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia.
    Stryckmans P; Debusscher L; Socquet M
    Cancer Res; 1976 Sep; 36(9 pt.1):3034-8. PubMed ID: 1067897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sister chromatid exchange and growth kinetics in chronic myeloid leukemia.
    Stoll C; Oberling F; Roth MP
    Cancer Res; 1982 Aug; 42(8):3240-3. PubMed ID: 6953996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of extramedullary hemopoiesis to the staging of chronic myeloid leukemia.
    Baccarani M; Zaccaria A; Bagnara GP; Santucci MA; Brunelli MA; Tura S
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):257-70. PubMed ID: 282897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD; Kirshner J
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro growth of human myeloid leukemia bone marrow cells in liquid culture.
    Ciani A; Vanin V; Maiolo AT; Polli EE
    Isr J Med Sci; 1978 Dec; 14(12):1231-5. PubMed ID: 285047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation and maturation of human leukemic cells in liquid culture: activity of human placenta conditioned medium and retinoic acid.
    Champelovier P; Seigneurin D
    Exp Hematol; 1985 Nov; 13(10):1094-100. PubMed ID: 3863756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetic parameters of proliferating granulocytes in patients with chronic myeloid leukemia].
    Petukhov VI; Bondare DK; Baravika IIa; Velik LV
    Ter Arkh; 1981; 53(9):39-45. PubMed ID: 6946604
    [No Abstract]   [Full Text] [Related]  

  • 13. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
    Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
    Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth pattern and SCE incidence in Ph1-positive cells of CML.
    Abe S; Kakati S; Sandberg AA
    Cytobios; 1980; 28(111-112):137-49. PubMed ID: 6938334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological and histoenzymatic characteristics of the bone marrow in the blastic crisis of chronic myeloleukosis].
    Khittsov GA
    Vopr Onkol; 1978; 24(1):24-9. PubMed ID: 273347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The parameters of cellular proliferation in acute (immature-cell) leukemias.
    Urasiński I; Kordecki H
    Pol Med Sci Hist Bull (1973); 1976; 15(3):305-10. PubMed ID: 995767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic crisis in previously clinically silent chronic myelogenous leukemia.
    Mintz U; Bar-Meir S; Pinkhas J; De Vries A
    Haematologia (Budap); 1975; 9(3-4):257-60. PubMed ID: 1065616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of marrow morphology and cytogenetics after blastic transformation in a case with chronic myelocytic leukemia (author's transl)].
    Sakurai T; Kudo H; Nagasawa T; Yoda Y; Kawada K
    Rinsho Ketsueki; 1975 Jun; 16(6):636-43. PubMed ID: 1057667
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
    Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.